UBM organizers of the CPhI Conference | 13 October, 2015

"A wide perspective, regarding the application of data integrity principles, should be applied in order to include all kinds and nature of data and records", he added.

The latest developments in the exciting sector of generics was the theme opening the first module in the Track Two sessions with Sandu, Managing Director of Reva Pharma speaking on how emerging markets are driving the transformation of the pharmaceutical industry.

"It's a time of changing priorities for the global pharma industry and as growth patterns in developed markets continue to flatten, innovator and generic companies are shifting focus in securing new sources of revenue and profitability in emerging markets," he said.

Noting that from next year, the industry is expected to generate an estimated 30 percent of total sales in emerging markets, Sandhu said that healthcare spending in those markets has already overtaken that of the EU's top markets, and that after BRICS, new opportunities are emerging in Turkey, Indonesia, Mexico, Vietnam, South Korea, and Poland.

"The challenge lying ahead for innovator and large generic companies is understanding the complex cultural norms of the emerging markets so they can position themselves," he explained

Ken Phelps, President and CEO of Camargo Pharmaceutical